Showing 1 - 10 of 805
Science and technology have come under the fire of critics over the last ten years or so, but the present situation of mankind will call for more, and not less, human ingenuity. A particular problem for Europe to master is the need to improve the channels for translating scientific achievements...
Persistent link: https://www.econbiz.de/10011557327
Persistent link: https://www.econbiz.de/10011551872
Persistent link: https://www.econbiz.de/10001482466
Persistent link: https://www.econbiz.de/10003931919
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10009659550
Persistent link: https://www.econbiz.de/10001531056
Foreign direct investment has grown rapidly in recent decades and, along with it, foreign research and development activities. The following article analyzes the reasons for the internationalization of R&D, examines its patterns in relationship to Germany and discusses the implications for...
Persistent link: https://www.econbiz.de/10011546781
Persistent link: https://www.econbiz.de/10001105662
Persistent link: https://www.econbiz.de/10011550006
economies are fuelling calls to contain the so-called evergreening practices of drug producers around the world. But such … exclusivity for pharmaceuticals products and evaluates safeguards against such evergreening. …
Persistent link: https://www.econbiz.de/10011311672